Fresenius SE & Co. KGaA (FSNUF)
OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous Close | 0.00 |
| Open | 33.70 |
| Bid | 34.45 x 40000 |
| Ask | 39.95 x 40000 |
| Day's Range | 33.70 - 33.70 |
| 52 Week Range | 25.77 - 37.08 |
| Volume | |
| Avg. Volume | 322 |
| Market Cap | 20.885B |
| Beta (5Y Monthly) | 1.07 |
| PE Ratio (TTM) | 57.05 |
| EPS (TTM) | 0.65 |
| Earnings Date | Nov 06, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | May 18, 2023 |
| 1y Target Est | 8.04 |
ZacksSteris (STE) Up 3% Since Last Earnings Report: Can It Continue?
Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Simply Wall St.Returns On Capital At Fresenius SE KGaA (ETR:FRE) Paint A Concerning Picture
When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...
ReutersFresenius beats Q2 view on strong unit performance, cost savings
(Reuters) -German healthcare group Fresenius beat second-quarter operating profit expectations on Wednesday, citing strong performance at its Kabi and Helios units, and progress in group-wide cost savings. It reported earnings before interests and taxes (EBIT) of 660 million euros ($714 million), up 16% from a year ago. Analysts were expecting an EBIT of 636 million euros, according to a consensus of forecasts from Vara Research.
© 2024 Yahoo. All rights reserved.